Skip to content

Efficacy of Jianpi Lishi in the Treatment of Palmar Hyperhidrosis Based on the Theory of "Pisiyunhua Zhusizhi"

Efficacy of Jianpi Lishi in the Treatment of Palmar Hyperhidrosis Based on the Theory of "Pisiyunhua Zhusizhi"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001734
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-09-19
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palmar Hyperhidrosis

Interventions

Experimental Group 1:Jianpi Lishui granules (Codonopsis Radix 30g, Poria 30g, fried Atractylodes 20g, Magnolia Bark 20g, Job's Tears 30g, etc.) taken orally, 1 dose per day, dissolved in water, 3 time
Experimental Group 2:Dissolve the Jianpi Lishui granules (Codonopsis Radix 30g, Poria 30g, fried Atractylodes 20g, Magnolia Bark 20g, Job's Tears 30g, etc.) in boiling water. Once the temperature of
dry your hands. Repeat once daily.Total treatment duration is 28 days.
Experimental Group 3:Jianpi Lishui granules, taken with water, 1 dose daily, 3 times a day, while also using Jianpi Lishui granules externally, once a day. Total treatment duration is 28 days.
Control group: Use Urotropine solution, apply an appropriate amount evenly on both palms, once a day. Total treatment duration is 28 days.

Sponsors

The General Hospital of Western Theater Command PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnosis criteria of Western medicine and Traditional Chinese Medicine, and the Hyperhidrosis Disease Severity Scale (HDSS) = 2 points. 2. Age 18-45 years. 3. No topical medications or surgical treatments related to this disease within 1 week before treatment, and no oral medication treatments associated with this disease within 2 weeks. 4. The patient is informed and consents to participate in this research study.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women. 2. Patients with compensatory hyperhidrosis after surgical treatment for primary palmar hyperhidrosis or secondary hyperhidrosis. 3. Patients with visceral diseases and tumors such as heart, liver, and kidney diseases. 4. Individuals allergic to the components of the study medication.

Design outcomes

Primary

MeasureTime frame
the Hyperhidrosis Disease Severity Scale (HDSS) ;

Secondary

MeasureTime frame
Weight change of sweating volume;Evaluation of Therapeutic Effects of Traditional Chinese Medicine Syndromes;

Countries

China

Contacts

Public ContactLuo Yong

The General Hospital of Western Theater Command PLA

yongl019@sina.com+86 136 2800 8919

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026